Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 128, Issue 2, Pages 301-313
Publisher
Springer Nature
Online
2010-08-04
DOI
10.1007/s10549-010-1055-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutant p53 mediates survival of breast cancer cells
- (2009) L Y Lim et al. BRITISH JOURNAL OF CANCER
- Synergistic effect of rapamycin and cisplatin in endometrial cancer cells
- (2009) Victoria L. Bae-Jump et al. CANCER
- mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
- (2009) S. Mabuchi et al. CLINICAL CANCER RESEARCH
- Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy
- (2009) Hai-Yan Zhang et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma
- (2009) O. Ekshyyan et al. MOLECULAR CANCER THERAPEUTICS
- Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
- (2008) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma
- (2008) Ka Ho Tam et al. CANCER LETTERS
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins
- (2008) Medhi Wangpaichitr et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Basal-Like Breast Cancer: A Critical Review
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide
- (2008) Tobias Sinnberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73
- (2008) J. M. Rosenbluth et al. MOLECULAR AND CELLULAR BIOLOGY
- Impact of Basal-Like Breast Carcinoma Determination for a More Specific Therapy
- (2008) Emad A. Rakha et al. PATHOBIOLOGY
- Triple-negative/basal-like breast cancer: review
- (2008) Emad A. Rakha et al. PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started